Document is current
Any future updates will be listed below
-
Authors
Ramirez, Sophia
Brown, Jasmine
Yang, Ryan
Deynzer, Marianna https://orcid.org/0009-0006-3045-7740
Lemos, Gabriela https://orcid.org/0000-0003-0943-1387
McCarthy, Cassidy
Dube, Sara
Virostko, John
Janumala, Isaiah
Nichols, Amy R. https://orcid.org/0000-0002-3085-7377
Rickman, Rachel
Foster, Saralyn F.
Cassidy, Michelle https://orcid.org/0000-0002-9348-8740
Heymsfield, Steven B. https://orcid.org/0000-0003-1127-9425
Widen, Elizabeth M. https://orcid.org/0000-0002-9574-6109
- License Information
-
More Information
Article History
Received: 18 August 2025
Revised: 9 April 2026
Accepted: 12 May 2026
First Online: 24 May 2026
Competing interests
: SBH serves on the Medical Advisory Boards of Tanita Corporation, Novo Nordisk, Lilly, Abbott, Regeneron, and Medifast. The other authors have no relevant conflicts of interest to disclose. The authors and their close relatives and their professional associates have no financial interests in the study outcome, nor do they serve as an officer, director, member, owner, trustee, or employee of an organization with a financial interest in the outcome or as an expert witness, advisor, consultant, or public advocate on behalf of an organization with a financial interest in the study outcome.
: The MINT Study is registered through was approved by the University of Texas Austin Institutional Review Board; all methods were performed in accordance with university guidelines and regulations, and all participants signed informed consent.
